Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page
- Check7 days agoChange DetectedAdded related topics sections for Prostate cancer and MedlinePlus Genetics, serving as navigation/context rather than core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoChange DetectedRevision: v3.4.2 was added, and the notice about government funding (and the prior Revision: v3.4.1) was removed.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated operation status guidance, including links to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; Deleted: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4. These are minor UI/copy and metadata changes that do not alter core study information or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedRelated topics now omit 'Prostate cancer' and 'MedlinePlus Genetics'. This removes disease context and linked educational resources from the page.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor changes include addition of related topics such as Prostate cancer and MedlinePlus Genetics, and a revision label update to v3.3.4 (replacing v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.